| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/20/2011 | CN101279040B Chinese medicinal active anti-cancer vaccine and method of preparing the same |
| 07/20/2011 | CN101250134B N-aryl-beta-aryl amidine-propionamide compounds, preparation method and use thereof |
| 07/20/2011 | CN101245106B Anti-VRGF acceptor monoclone antibody, preparation method and application thereof |
| 07/20/2011 | CN101244036B High dispersion does type containing cholesterol group phosphoryl nucleoside analogue |
| 07/20/2011 | CN101054380B Pyrazolopyrimidine derivative used as cell cycle dependency protein kinase inhibitor |
| 07/20/2011 | CN101041646B Preparation method and usage for nitrogen-containing chalcone derivatives |
| 07/20/2011 | CN101006997B Compound taxol and its derivative docetaxel fat emulsion and preparation method |
| 07/20/2011 | CA2784918A1 Antimir-451 for the treatment of polycythemias |
| 07/19/2011 | US7982041 Camptothecin analogs and methods of preparation thereof |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7982033 Pyrrolotriazine kinase inhibitors |
| 07/19/2011 | US7982024 Antibodies to insulin-like growth factor I receptor |
| 07/19/2011 | US7982015 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 07/19/2011 | US7981902 Substituted pyrrolo[2,3-d]pyrimidines for selectively targeting tumor cells with FR type receptors |
| 07/19/2011 | US7981895 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group |
| 07/19/2011 | US7981676 Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 07/19/2011 | US7981673 Process for the maturation of dendritic cells and a vaccine |
| 07/19/2011 | US7981669 Viral vectors |
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981601 Method of preparing polyepitope chimeric gene vaccine |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981419 Method for treating hypophosphatemic bone diseases using FGF-23 antibody |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2526663C Indole derivatives with apoptosis-inducing effect |
| 07/19/2011 | CA2509390C Method of treatment of prostate cancer and composition for treatment thereof |
| 07/19/2011 | CA2485702C Novel phosphonic acid based prodrugs of pmea and its analogues |
| 07/19/2011 | CA2485503C Phenyl-thiophene type vitamin d receptor modulators |
| 07/19/2011 | CA2477232C Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 07/19/2011 | CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/19/2011 | CA2475818C Aryl ureas as kinase inhibitors |
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/19/2011 | CA2465272C Separation of regioisomers of metal phthalocyanines |
| 07/19/2011 | CA2463300C Thiopene- and thiazolesulfonamides as antineoplastic agents |
| 07/19/2011 | CA2459165C Dosage forms having prolonged active ingredient release |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2440890C Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 07/19/2011 | CA2431606C Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 07/19/2011 | CA2420279C Selective androgen receptor modulators and methods of use thereof |
| 07/19/2011 | CA2401906C Kcnb: a novel potassium channel protein |
| 07/19/2011 | CA2400403C 1-nitroacridine/tumor inhibitor compositions |
| 07/19/2011 | CA2397354C O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/19/2011 | CA2344169C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/19/2011 | CA2308584C Targeted liposome gene delivery |
| 07/19/2011 | CA2188560C Compositions comprising dna damaging agents and p53 |
| 07/14/2011 | WO2011085276A2 Methods and kits to predict prognostic and therapeutic outcome in small cell lung cancer |
| 07/14/2011 | WO2011085162A2 Topical transdermal dexmedetomidine compositions and methods of use thereof |
| 07/14/2011 | WO2011085039A2 Use of histone acetyltransferase inhibitors as novel anti-cancer therapies |
| 07/14/2011 | WO2011084968A1 A combination of an immunomodulatory compound and an artemisinin or a derivative thereof for treating cancer |
| 07/14/2011 | WO2011084962A1 Analogs of dehydrophenylahistins |
| 07/14/2011 | WO2011084726A1 BIS [4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM] 4-[(3-CARBOXYLATO-2-HYDROXYNAPHTHALEN-1-YL)METHYL]-3-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS |
| 07/14/2011 | WO2011084725A1 4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM 1-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS |
| 07/14/2011 | WO2011084685A2 Saposin-a derived peptides and uses thereof |
| 07/14/2011 | WO2011084623A1 Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment |
| 07/14/2011 | WO2011084620A2 Particles for multiple agent delivery |
| 07/14/2011 | WO2011084571A2 Azide derivatives for phototherapy |
| 07/14/2011 | WO2011084523A2 Ulk1 compositions, inhibitors, screening and methods of use |
| 07/14/2011 | WO2011084458A2 Polymer-based compositions and methods for treatment of peritoneal disorders |
| 07/14/2011 | WO2011084451A2 Methods and compositions for liquidation of tumors |
| 07/14/2011 | WO2011084439A1 Tetrahydrocarboline derivatives as eg5 inhibitors |
| 07/14/2011 | WO2011084366A2 Methods, compositions and drug delivery systems for intraocular delivery of sirna molecules |
| 07/14/2011 | WO2011084108A1 Methods and compositions for treating cancer |
| 07/14/2011 | WO2011083999A2 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient |
| 07/14/2011 | WO2011083998A2 Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient |
| 07/14/2011 | WO2011083830A1 Novel anticancer agent and method for screening same |
| 07/14/2011 | WO2011083637A1 Therapeutic agent for hepatic disorder |
| 07/14/2011 | WO2011083091A2 Methods for treating pancreatic cancer |
| 07/14/2011 | WO2011082519A1 Geldanamycin derivatives, preparation methods and uses thereof |
| 07/14/2011 | WO2011082488A1 Bisphenol derivative therapeutics and methods for their use |
| 07/14/2011 | WO2011082487A1 Bisphenol derivatives and their use as androgen receptor activity modulators |
| 07/14/2011 | WO2011082458A1 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with these diseases, such as cachexia, and remedying adverse effects of drugs and treatments, such as immunodepression, neutropenia and lymphocytopenia, comprising the association or combination of a specially selected biological response modifier and other antineoplastic compounds and/or other treatments |
| 07/14/2011 | WO2011054001A8 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 07/14/2011 | WO2011049289A3 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells |
| 07/14/2011 | WO2011040613A8 Therapeutic agent for tumor |
| 07/14/2011 | WO2011039629A3 Bioactive fraction of petiveria alliacea, pharmaceutical composition containing same, and combination with immunostimulants for treating cancer |
| 07/14/2011 | WO2011038924A9 Proteasome inhibitors for treating cancer |
| 07/14/2011 | WO2011033265A8 Pharmaceutical compounds |
| 07/14/2011 | WO2011031460A3 Novel anti-inflammatory peptides that bind oxidized phospholipids |
| 07/14/2011 | WO2011028485A3 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 07/14/2011 | WO2011028255A3 Desferrithiocin polyether analogues and uses thereof |
| 07/14/2011 | WO2011021864A3 Novel compound for complementing anticancer drugs, a production method for the same, a composition for complementing anticancer drugs comprising the same, and a method for reducing resistance to anticancer drugs using the same |
| 07/14/2011 | WO2011020933A3 Liposomes covered with the extracellular domain of the apo2l/trail protein |
| 07/14/2011 | WO2011009977A3 Use of a composition containing an extract of a gramineous plant for the prevention of cutaneous lesions caused by ultraviolet radiation |
| 07/14/2011 | WO2010042644A8 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines |
| 07/14/2011 | US20110173709 Ectopic, orthotopic model for revascularization and tumor assessment |
| 07/14/2011 | US20110172446 Methods and compositions for use in treating cancer |
| 07/14/2011 | US20110172308 Antagonsim of PGF2a Receptor to Treat Hyertension Characterized by Activation of the Renin-Angiotensin-Aldosterone System |
| 07/14/2011 | US20110172295 METHODS AND COMPOSITIONS FOR THE REGULATION OF microRNA PROCESSING |
| 07/14/2011 | US20110172294 Cyclohexenyl nucleic acids analogs |
| 07/14/2011 | US20110172293 Methods and Compositions for Modulating Angiogenesis |
| 07/14/2011 | US20110172292 Antidote oligomers |
| 07/14/2011 | US20110172289 Minor groove binder (mgb)-oligonucleotide mirna antagonists |
| 07/14/2011 | US20110172288 Compositions and Methods for the Identification, Assessment, Prevention and Therapy of Thymic Lymphoma or Hamartomatous Tumours |
| 07/14/2011 | US20110172287 Compositions and methods for inhibiting tumor growth and metastasis |
| 07/14/2011 | US20110172285 Proteasome inhibitors |
| 07/14/2011 | US20110172282 Use of spiro-oxindole compounds as therapeutic agents |
| 07/14/2011 | US20110172279 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/14/2011 | US20110172275 Pyrrole compounds |
| 07/14/2011 | US20110172267 TSH receptor antagonizing tetrahydroquinoline compounds |
| 07/14/2011 | US20110172261 DIBENZO[f,h]ISOQUINOLINE DERIVATIVES |